Wilmer Cutler Pickering Hale and Dorr represented Telix Pharmaceuticals Limited in the transaction. Telix Pharmaceuticals Limited (ASX: TLX) (Telix), a biopharmaceutical company, announced its acquisition of...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr is representing WEX in the transaction. WEX (NYSE: WEX) announced the signing of a definitive agreement to acquire Payzer. Pursuant to...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis represented Lilly, while Wilmer Cutler Pickering Hale and Dorr represented Akouos in the transaction. Eli Lilly and Company (NYSE: LLY) announced its acquisition...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised Progress on the deal, while Lowenstein represented Mill Point Capital. Progress, the leading provider of products to develop, deploy...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised PerkinElmer on the deal while Pillsbury Winthrop Shaw Pittman represented BioLegend. PerkinElmer, a global leader committed to innovating for...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr LLP advised WEX, Inc. on the deal. WEX, Inc., a leading financial technology service provider, announced the signing of an...
You must be a Standard 1 Year member to access this content.
